(MedPage Today) — Ambroxol, a common cough medicine used in Europe, demonstrated target engagement in people with Parkinson’s disease dementia but did not show an effect on cognition compared with placebo, a year-long phase II trial showed.
Looking…
Source link : https://www.medpagetoday.com/neurology/parkinsonsdisease/116352
Author :
Publish date : 2025-07-02 14:35:00
Copyright for syndicated content belongs to the linked Source.
